These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 11012092)

  • 1. Characterization of the interaction of recombinant apolipoprotein(a) with modified fibrinogen surfaces and fibrin clots.
    Sangrar W; Koschinsky ML
    Biochem Cell Biol; 2000; 78(4):519-25. PubMed ID: 11012092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The solution phase interaction between apolipoprotein(a) and plasminogen inhibits the binding of plasminogen to a plasmin-modified fibrinogen surface.
    Sangrar W; Gabel BR; Boffa MB; Walker JB; Hancock MA; Marcovina SM; Horrevoets AJ; Nesheim ME; Koschinsky ML
    Biochemistry; 1997 Aug; 36(34):10353-63. PubMed ID: 9265615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of Apo(a) kringle IV-10 and plasminogen kringles on the interactions of lipoprotein(a) with regulatory molecules.
    Xue S; Green MA; LoGrasso PV; Boettcher BR; Madison EL; Curtiss LK; Miles LA
    Thromb Haemost; 1999 Mar; 81(3):428-35. PubMed ID: 10102473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequences within apolipoprotein(a) kringle IV types 6-8 bind directly to low-density lipoprotein and mediate noncovalent association of apolipoprotein(a) with apolipoprotein B-100.
    Gabel BR; Koschinsky ML
    Biochemistry; 1998 May; 37(21):7892-8. PubMed ID: 9601051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Kringle V-protease domain is a fibrinogen binding region within Apo(a).
    Xue S; Madison EL; Miles LA
    Thromb Haemost; 2001 Nov; 86(5):1229-37. PubMed ID: 11816712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifibrinolytic effect of single apo(a) kringle domains: relationship to fibrinogen binding.
    Rahman MN; Petrounevitch V; Jia Z; Koschinsky ML
    Protein Eng; 2001 Jun; 14(6):427-38. PubMed ID: 11477223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of recombinant apolipoprotein(a) to human platelets and effect on platelet aggregation.
    Martínez C; Rivera J; Loyau S; Corral J; González-Conejero R; Lozano ML; Vicente V; Anglés-Cano E
    Thromb Haemost; 2001 Apr; 85(4):686-93. PubMed ID: 11341506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baboon lipoprotein(a) binds very weakly to lysine-agarose and fibrin despite the presence of a strong lysine-binding site in apolipoprotein(a) kringle IV type 10.
    Belczewski AR; Ho J; Taylor FB; Boffa MB; Jia Z; Koschinsky ML
    Biochemistry; 2005 Jan; 44(2):555-64. PubMed ID: 15641780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cloning of the cDNA encoding the carboxy-terminal domain of chimpanzee apolipoprotein(a): an Asp57 --> Asn mutation in kringle IV-10 is associated with poor fibrin binding.
    Chenivesse X; Huby T; Wickins J; Chapman J; Thillet J
    Biochemistry; 1998 May; 37(20):7213-23. PubMed ID: 9585533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH; Diamond SL
    Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of sequences in apolipoprotein(a) that maintain its closed conformation: a novel role for apo(a) isoform size in determining the efficiency of covalent Lp(a) formation.
    Becker L; Cook PM; Koschinsky ML
    Biochemistry; 2004 Aug; 43(31):9978-88. PubMed ID: 15287725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Definition of the structural elements in plasminogen required for high-affinity binding to apolipoprotein(a): a study utilizing surface plasmon resonance.
    Hancock MA; Spencer CA; Koschinsky ML
    Biochemistry; 2004 Sep; 43(38):12237-48. PubMed ID: 15379562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of synthetic B knobs to fibrinogen changes the character of fibrin and inhibits its ability to activate tissue plasminogen activator and its destruction by plasmin.
    Doolittle RF; Pandi L
    Biochemistry; 2006 Feb; 45(8):2657-67. PubMed ID: 16489759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein(a) and plasminogen interactions with fibrin: a study with recombinant apolipoprotein(a) and isolated plasminogen fragments.
    Rouy D; Koschinsky ML; Fleury V; Chapman J; Anglés-Cano E
    Biochemistry; 1992 Jul; 31(27):6333-9. PubMed ID: 1627572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual effect of apolipoprotein(a) on plasmin(ogen)-induced apoptosis through modulation of cell detachment of adherent cells.
    Ho-Tin-Noé B; Meilhac O; Rossignol P; Lijnen HR; Anglés-Cano E
    Thromb Haemost; 2006 Jan; 95(1):142-50. PubMed ID: 16543973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein(a): structure-function relationship at the lysine-binding site and plasminogen activator cleavage site.
    Anglés-Cano E; Rojas G
    Biol Chem; 2002 Jan; 383(1):93-9. PubMed ID: 11928826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiangiogenic kringles derived from human plasminogen and apolipoprotein(a) inhibit fibrinolysis through a mechanism that requires a functional lysine-binding site.
    Ahn JH; Lee HJ; Lee EK; Yu HK; Lee TH; Yoon Y; Kim SJ; Kim JS
    Biol Chem; 2011 Apr; 392(4):347-56. PubMed ID: 21194375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lp(a) particles mold fibrin-binding properties of apo(a) in size-dependent manner: a study with different-length recombinant apo(a), native Lp(a), and monoclonal antibody.
    Kang C; Dominguez M; Loyau S; Miyata T; Durlach V; Anglés-Cano E
    Arterioscler Thromb Vasc Biol; 2002 Jul; 22(7):1232-8. PubMed ID: 12117743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of lipoprotein(a) on the binding of plasminogen to fibrin and its activation by fibrin-bound tissue-type plasminogen activator.
    Anglés-Cano E; Hervio L; Rouy D; Fournier C; Chapman JM; Laplaud M; Koschinsky ML
    Chem Phys Lipids; 1994 Jan; 67-68():369-80. PubMed ID: 8187237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple binding with identical linkage: a mechanism that explains the effect of lipoprotein(a) on fibrinolysis.
    Hervio L; Durlach V; Girard-Globa A; Anglés-Cano E
    Biochemistry; 1995 Oct; 34(41):13353-8. PubMed ID: 7577920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.